mitogen-activated protein kinase kinase kinase kinase 5
|
nd/KHS(MAP4K5) |
Hs |
Inhibitor |
Inhibition |
0.8
|
|
|
fms related receptor tyrosine kinase 3
|
Flt3/FLT3 |
Hs |
Inhibitor |
Inhibition |
0.8
|
1.0
|
-1.0
|
leucine rich repeat kinase 2
|
nd/LRRK2 |
Hs |
Inhibitor |
Inhibition |
1.4
|
|
|
neurotrophic receptor tyrosine kinase 3
|
nd/TRKC |
Hs |
Inhibitor |
Inhibition |
1.9
|
|
|
NUAK family kinase 1
|
ARK5/ARK5(NUAK1) |
Hs |
Inhibitor |
Inhibition |
2.1
|
6.0
|
6.0
|
ret proto-oncogene
|
Ret/RET |
Hs |
Inhibitor |
Inhibition |
2.5
|
-1.0
|
-1.0
|
serine/threonine kinase 4
|
MST1/MST1(STK4) |
Hs |
Inhibitor |
Inhibition |
3.0
|
12.0
|
5.0
|
phosphorylase kinase catalytic subunit gamma 1
|
nd/PHKg1 |
Hs |
Inhibitor |
Inhibition |
3.2
|
|
|
mitogen-activated protein kinase kinase kinase 7
|
TAK1/TAK1 |
Hs |
Inhibitor |
Inhibition |
3.5
|
4.0
|
-3.0
|
ALK receptor tyrosine kinase
|
ALK/ALK |
Hs |
Inhibitor |
Inhibition |
3.5
|
8.0
|
2.0
|
calcium/calmodulin-dependent protein kinase II alpha subunit
|
nd/CAMK2a |
Hs |
Inhibitor |
Inhibition |
3.6
|
|
|
mitogen-activated protein kinase kinase kinase kinase 4
|
nd/HGK(MAP4K4) |
Hs |
Inhibitor |
Inhibition |
4.3
|
|
|
Insulin receptor-related receptor
|
IRR/IRR(INSRR) |
Hs |
Inhibitor |
Inhibition |
4.3
|
13.0
|
0.0
|
misshapen like kinase 1
|
MINK/MINK(MINK1) |
Hs |
Inhibitor |
Inhibition |
4.4
|
9.0
|
2.0
|
YES proto-oncogene 1, Src family tyrosine kinase
|
Tes/YES(YES1) |
Hs |
Inhibitor |
Inhibition |
5.3
|
2.0
|
-1.0
|
LYN proto-oncogene, Src family tyrosine kinase
|
Lyn/LYN |
Hs |
Inhibitor |
Inhibition |
6.3
|
2.0
|
3.0
|
checkpoint kinase 2
|
CHK2/CHK2 |
Hs |
Inhibitor |
Inhibition |
6.4
|
6.0
|
1.0
|
serine/threonine kinase 10
|
LOK/LOK(STK10) |
Hs |
Inhibitor |
Inhibition |
7.1
|
15.0
|
5.0
|
microtubule affinity regulating kinase 4
|
nd/MARK4 |
Hs |
Inhibitor |
Inhibition |
7.2
|
|
|
calcium/calmodulin-dependent protein kinase II delta subunit
|
CaMKIIδ/CAMK2d |
Hs |
Inhibitor |
Inhibition |
7.2
|
3.0
|
1.0
|
colony stimulating factor 1 receptor
|
Fms/FMS |
Hs |
Inhibitor |
Inhibition |
7.4
|
0.0
|
0.0
|
microtubule affinity regulating kinase 3
|
nd/MARK3 |
Hs |
Inhibitor |
Inhibition |
7.9
|
|
|
protein kinase D3
|
nd/PKCnu(PRKD3) |
Hs |
Inhibitor |
Inhibition |
8.0
|
|
|
mitogen-activated protein kinase kinase kinase kinase 2
|
GCK/GCK(MAP4K2) |
Hs |
Inhibitor |
Inhibition |
8.1
|
5.0
|
0.0
|
calcium/calmodulin-dependent protein kinase II gamma subunit
|
CaMKIIγ/CAMK2g |
Hs |
Inhibitor |
Inhibition |
8.1
|
3.0
|
0.0
|
neurotrophic receptor tyrosine kinase 2
|
TrkB/TRKB |
Hs |
Inhibitor |
Inhibition |
8.4
|
40.0
|
-12.0
|
testis specific serine kinase 1B
|
TSSK1/STK22D(TSSK1) |
Hs |
Inhibitor |
Inhibition |
8.4
|
8.0
|
0.0
|
neurotrophic receptor tyrosine kinase 1
|
TrkA/TRKA |
Hs |
Inhibitor |
Inhibition |
8.7
|
-1.0
|
0.0
|
platelet derived growth factor receptor beta
|
PDGFRβ/PDGFRb |
Hs |
Inhibitor |
Inhibition |
9.3
|
1.0
|
1.0
|
microtubule affinity regulating kinase 2
|
PAR-1Bα/MARK2(PAR-1Ba) |
Hs |
Inhibitor |
Inhibition |
9.7
|
11.0
|
3.0
|
myosin light chain kinase 2
|
nd/MLCK2(MYLK2) |
Hs |
Inhibitor |
Inhibition |
10.0
|
|
|
ribosomal protein S6 kinase A2
|
Rsk3/RSK3 |
Hs |
Inhibitor |
Inhibition |
10.0
|
9.0
|
1.0
|
ribosomal protein S6 kinase A6
|
Rsk4/RSK4 |
Hs |
Inhibitor |
Inhibition |
10.5
|
14.0
|
9.0
|
protein kinase D1
|
PKCμ/PKCmu(PRKD1) |
Hs |
Inhibitor |
Inhibition |
11.3
|
38.0
|
4.0
|
FGR proto-oncogene, Src family tyrosine kinase
|
Fgr/FGR |
Hs |
Inhibitor |
Inhibition |
11.5
|
8.0
|
2.0
|
MER proto-oncogene, tyrosine kinase
|
Mer/c-MER |
Hs |
Inhibitor |
Inhibition |
11.5
|
7.0
|
0.0
|
leukocyte receptor tyrosine kinase
|
nd/TYK1(LTK) |
Hs |
Inhibitor |
Inhibition |
11.6
|
|
|
LCK proto-oncogene, Src family tyrosine kinase
|
Lck/LCK |
Hs |
Inhibitor |
Inhibition |
11.8
|
12.0
|
2.0
|
protein kinase D2
|
PKD2/PKD2(PRKD2) |
Hs |
Inhibitor |
Inhibition |
11.9
|
73.0
|
16.0
|
fms related receptor tyrosine kinase 4
|
Flt4/FLT4 |
Hs |
Inhibitor |
Inhibition |
12.1
|
0.0
|
1.0
|
fibroblast growth factor receptor 3
|
FGFR3/FGFR3 |
Hs |
Inhibitor |
Inhibition |
12.3
|
8.0
|
1.0
|
ribosomal protein S6 kinase A1
|
Rsk1/RSK1 |
Hs |
Inhibitor |
Inhibition |
13.1
|
11.0
|
2.0
|
unc-51 like autophagy activating kinase 1
|
nd/ULK1 |
Hs |
Inhibitor |
Inhibition |
13.6
|
|
|
kinase insert domain receptor
|
KDR/KDR(VEGFR2) |
Hs |
Inhibitor |
Inhibition |
13.8
|
2.0
|
1.0
|
interleukin 1 receptor associated kinase 1
|
IRAK1/IRAK1 |
Hs |
Inhibitor |
Inhibition |
14.1
|
9.0
|
0.0
|
ribosomal protein S6 kinase A3
|
Rsk2/RSK2 |
Hs |
Inhibitor |
Inhibition |
15.1
|
11.0
|
1.0
|
checkpoint kinase 1
|
CHK1/CHK1 |
Hs |
Inhibitor |
Inhibition |
15.1
|
24.0
|
3.0
|
CDC like kinase 2
|
CLK2/CLK2 |
Hs |
Inhibitor |
Inhibition |
15.8
|
9.0
|
1.0
|
BLK proto-oncogene, Src family tyrosine kinase
|
Blk/BLK |
Hs |
Inhibitor |
Inhibition |
15.8
|
1.0
|
0.0
|
serine/threonine kinase 17a
|
DRAK1/DRAK1(STK17A) |
Hs |
Inhibitor |
Inhibition |
16.1
|
3.0
|
2.0
|
TANK binding kinase 1
|
TBK1/TBK1 |
Hs |
Inhibitor |
Inhibition |
16.3
|
15.0
|
1.0
|
phosphorylase kinase catalytic subunit gamma 2
|
PhKγ2/PHKg2 |
Hs |
Inhibitor |
Inhibition |
16.6
|
8.0
|
2.0
|
maternal embryonic leucine zipper kinase
|
MELK/MELK |
Hs |
Inhibitor |
Inhibition |
16.7
|
8.0
|
3.0
|
CDC like kinase 4
|
nd/CLK4 |
Hs |
Inhibitor |
Inhibition |
16.8
|
|
|
serine/threonine kinase 3
|
MST2/MST2(STK3) |
Hs |
Inhibitor |
Inhibition |
16.9
|
34.0
|
2.0
|
myosin light chain kinase
|
MLCK/MLCK(MYLK) |
Hs |
Inhibitor |
Inhibition |
17.6
|
9.0
|
3.0
|
FER tyrosine kinase
|
Fer/FER |
Hs |
Inhibitor |
Inhibition |
17.7
|
79.0
|
14.0
|
microtubule affinity regulating kinase 1
|
MARK1/MARK1 |
Hs |
Inhibitor |
Inhibition |
18.1
|
14.0
|
3.0
|
homeodomain interacting protein kinase 2
|
HIPK2/HIPK2 |
Hs |
Inhibitor |
Inhibition |
20.0
|
6.0
|
1.0
|
mitogen-activated protein kinase kinase kinase 2
|
nd/MEKK2 |
Hs |
Inhibitor |
Inhibition |
20.1
|
|
|
fibroblast growth factor receptor 1
|
FGFR1/FGFR1 |
Hs |
Inhibitor |
Inhibition |
20.3
|
7.0
|
1.0
|
serine/threonine kinase 33
|
STK33/STK33 |
Hs |
Inhibitor |
Inhibition |
20.6
|
33.0
|
6.0
|
mitogen-activated protein kinase kinase kinase 11
|
nd/MLK3(MAP3K11) |
Hs |
Inhibitor |
Inhibition |
21.0
|
|
|
unc-51 like kinase 3
|
ULK3/ULK3 |
Hs |
Inhibitor |
Inhibition |
21.6
|
17.0
|
2.0
|
LYN proto-oncogene, Src family tyrosine kinase
|
nd/LYN B |
Hs |
Inhibitor |
Inhibition |
21.9
|
|
|
FES proto-oncogene, tyrosine kinase
|
Fes/FES |
Hs |
Inhibitor |
Inhibition |
22.1
|
14.0
|
2.0
|
serine/threonine kinase 24
|
MST3/MST3(STK24) |
Hs |
Inhibitor |
Inhibition |
22.2
|
8.0
|
1.0
|
tyrosine kinase non receptor 2
|
ACK1/ACK1 |
Hs |
Inhibitor |
Inhibition |
22.6
|
25.0
|
1.0
|
interleukin 1 receptor associated kinase 4
|
IRAK4/IRAK4 |
Hs |
Inhibitor |
Inhibition |
22.7
|
22.0
|
7.0
|
TYRO3 protein tyrosine kinase
|
Rse/TYRO3(SKY) |
Hs |
Inhibitor |
Inhibition |
23.2
|
24.0
|
-1.0
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
Abl/ABL1 |
Hs |
Inhibitor |
Inhibition |
24.7
|
23.0
|
0.0
|
AXL receptor tyrosine kinase
|
Axl/AXL |
Hs |
Inhibitor |
Inhibition |
25.2
|
9.0
|
1.0
|
protein tyrosine kinase 2
|
FAK/FAK(PTK2) |
Hs |
Inhibitor |
Inhibition |
25.8
|
15.0
|
4.0
|
platelet derived growth factor receptor alpha
|
PDGFRα/PDGFRa |
Hs |
Inhibitor |
Inhibition |
25.9
|
2.0
|
1.0
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
cSrc/c-SRC |
Hs |
Inhibitor |
Inhibition |
26.0
|
48.0
|
13.0
|
calcium/calmodulin-dependent protein kinase II beta subunit
|
CaMKIIβ/CAMK2b |
Hs |
Inhibitor |
Inhibition |
27.3
|
8.0
|
1.0
|
cyclin dependent kinase 6
|
CDK6-cyclin D3/CDK6-cyclin D1 |
Hs |
Inhibitor |
Inhibition |
27.8
|
70.0
|
13.0
|
FYN proto-oncogene, Src family tyrosine kinase
|
Fyn/FYN |
Hs |
Inhibitor |
Inhibition |
28.4
|
6.0
|
1.0
|
KIT proto-oncogene, receptor tyrosine kinase
|
cKit/c-Kit |
Hs |
Inhibitor |
Inhibition |
28.7
|
-1.0
|
0.0
|
fibroblast growth factor receptor 2
|
FGFR2/FGFR2 |
Hs |
Inhibitor |
Inhibition |
29.3
|
14.0
|
3.0
|
inhibitor of nuclear factor kappa B kinase subunit epsilon
|
nd/IKKe(IKBKE) |
Hs |
Inhibitor |
Inhibition |
29.4
|
|
|
IL2 inducible T cell kinase
|
Itk/ITK |
Hs |
Inhibitor |
Inhibition |
30.0
|
21.0
|
2.0
|
Insulin receptor
|
IR/IR |
Hs |
Inhibitor |
Inhibition |
30.1
|
32.0
|
6.0
|
protein tyrosine kinase 2 beta
|
Pyk2/PYK2 |
Hs |
Inhibitor |
Inhibition |
30.5
|
15.0
|
3.0
|
mitogen-activated protein kinase kinase kinase 3
|
nd/MEKK3 |
Hs |
Inhibitor |
Inhibition |
30.6
|
|
|
tyrosine kinase 2
|
nd/TYK2 |
Hs |
Inhibitor |
Inhibition |
30.8
|
|
|
aurora kinase B
|
Aurora-B/Aurora B |
Hs |
Inhibitor |
Inhibition |
31.9
|
7.0
|
1.0
|
mitogen-activated protein kinase kinase 1
|
MEK1/MEK1 |
Hs |
Inhibitor |
Inhibition |
33.1
|
21.0
|
8.0
|
CDC like kinase 1
|
nd/CLK1 |
Hs |
Inhibitor |
Inhibition |
34.2
|
|
|
HCK proto-oncogene, Src family tyrosine kinase
|
Hck/HCK |
Hs |
Inhibitor |
Inhibition |
34.3
|
13.0
|
3.0
|
fms related receptor tyrosine kinase 1
|
Flt1/FLT1(VEGFR1) |
Hs |
Inhibitor |
Inhibition |
34.4
|
5.0
|
0.0
|
Insulin-like growth factor I receptor
|
IGF-1R/IGF1R |
Hs |
Inhibitor |
Inhibition |
35.2
|
135.0
|
13.0
|
protein kinase N1
|
nd/PKN1(PRK1) |
Hs |
Inhibitor |
Inhibition |
36.5
|
|
|
BR serine/threonine kinase 1
|
BrSK1/BRSK1 |
Hs |
Inhibitor |
Inhibition |
36.5
|
6.0
|
9.0
|
STE20 like kinase
|
nd/SLK(STK2) |
Hs |
Inhibitor |
Inhibition |
38.0
|
|
|
Janus kinase 3
|
JAK3/JAK3 |
Hs |
Inhibitor |
Inhibition |
39.3
|
62.0
|
16.0
|
cyclin dependent kinase 9
|
nd/CDK9 cyclin K |
Hs |
Inhibitor |
Inhibition |
40.1
|
|
|
myosin IIIB
|
nd/MYO3b |
Hs |
Inhibitor |
Inhibition |
41.3
|
|
|
mitogen-activated protein kinase kinase 2
|
nd/MEK2 |
Hs |
Inhibitor |
Inhibition |
41.4
|
|
|
cyclin dependent kinase 6
|
nd/CDK6-cyclin D3 |
Hs |
Inhibitor |
Inhibition |
41.6
|
|
|
ribosomal protein S6 kinase B1
|
p70S6K/p70S6K(RPS6KB1) |
Hs |
Inhibitor |
Inhibition |
41.7
|
24.0
|
4.0
|
salt inducible kinase 2
|
nd/SIK2 |
Hs |
Inhibitor |
Inhibition |
42.7
|
|
|
unc-51 like autophagy activating kinase 2
|
ULK2/ULK2 |
Hs |
Inhibitor |
Inhibition |
43.0
|
23.0
|
2.0
|
c-ros oncogene 1, receptor tyrosine kinase
|
Ros/ROS(ROS1) |
Hs |
Inhibitor |
Inhibition |
43.9
|
106.0
|
87.0
|
casein kinase 1 gamma 2
|
CK1γ2/CK1g2 |
Hs |
Inhibitor |
Inhibition |
45.2
|
30.0
|
0.0
|
TAO kinase 3
|
TAO3/TAOK3(JIK) |
Hs |
Inhibitor |
Inhibition |
45.5
|
79.0
|
24.0
|
EPH receptor A6
|
nd/EPHA6 |
Hs |
Inhibitor |
Inhibition |
45.7
|
|
|
G protein-coupled receptor kinase 6
|
GRK6/GRK6 |
Hs |
Inhibitor |
Inhibition |
46.3
|
68.0
|
17.0
|
casein kinase 1 epsilon
|
nd/CK1epsilon |
Hs |
Inhibitor |
Inhibition |
46.7
|
|
|
ABL proto-oncogene 2, non-receptor tyrosine kinase
|
Arg/ABL2(ARG) |
Hs |
Inhibitor |
Inhibition |
46.8
|
47.0
|
7.0
|
dual specificity tyrosine phosphorylation regulated kinase 1A
|
nd/DYRK1(DYRK1A) |
Hs |
Inhibitor |
Inhibition |
47.2
|
|
|
dual specificity tyrosine phosphorylation regulated kinase 1B
|
nd/DYRK1B |
Hs |
Inhibitor |
Inhibition |
47.5
|
|
|
death associated protein kinase 1
|
DAPK1/DAPK1 |
Hs |
Inhibitor |
Inhibition |
47.7
|
75.0
|
31.0
|
casein kinase 1 gamma 3
|
CK1γ3/CK1g3 |
Hs |
Inhibitor |
Inhibition |
47.7
|
42.0
|
11.0
|
calcium/calmodulin dependent protein kinase kinase 1
|
nd/CAMKK1 |
Hs |
Inhibitor |
Inhibition |
47.7
|
|
|
calcium/calmodulin dependent protein kinase kinase 2
|
nd/CAMKK2 |
Hs |
Inhibitor |
Inhibition |
48.0
|
|
|
calcium/calmodulin dependent protein kinase IG
|
nd/CAMK1g |
Hs |
Inhibitor |
Inhibition |
49.5
|
|
|
mitogen-activated protein kinase kinase kinase 9
|
MLK1/MLK19MAP3K90 |
Hs |
Inhibitor |
Inhibition |
49.6
|
24.0
|
4.0
|
serum/glucocorticoid regulated kinase 1
|
SGK/SGK1 |
Hs |
Inhibitor |
Inhibition |
49.6
|
59.0
|
23.0
|
casein kinase 1 delta
|
CK1δ/CK1d |
Hs |
Inhibitor |
Inhibition |
49.7
|
23.0
|
5.0
|
homeodomain interacting protein kinase 3
|
HIPK3/HIPK3 |
Hs |
Inhibitor |
Inhibition |
50.8
|
9.0
|
-5.0
|
protein tyrosine kinase 6
|
BRK/BRK |
Hs |
Inhibitor |
Inhibition |
51.3
|
65.0
|
11.0
|
BR serine/threonine kinase 2
|
BrSK2/BRSK2 |
Hs |
Inhibitor |
Inhibition |
53.7
|
29.0
|
10.0
|
Janus kinase 2
|
JAK2/JAK2 |
Hs |
Inhibitor |
Inhibition |
54.0
|
72.0
|
20.0
|
death associated protein kinase 3
|
ZIPK/ZIPK(DAPK3) |
Hs |
Inhibitor |
Inhibition |
54.3
|
44.0
|
17.0
|
serine/threonine kinase 25
|
nd/STK25(YSK1) |
Hs |
Inhibitor |
Inhibition |
56.1
|
|
|
Bruton tyrosine kinase
|
BTK/BTK |
Hs |
Inhibitor |
Inhibition |
58.3
|
83.0
|
17.0
|
cyclin dependent kinase 9
|
CDK9-cyclin T1/CDK9-cyclin T1 |
Hs |
Inhibitor |
Inhibition |
58.8
|
48.0
|
13.0
|
p21 (RAC1) activated kinase 5
|
PAK5/PAK5 |
Hs |
Inhibitor |
Inhibition |
58.9
|
30.0
|
8.0
|
ribosomal protein S6 kinase A4
|
MSK2/MSK2(RPS6KA4) |
Hs |
Inhibitor |
Inhibition |
59.0
|
42.0
|
15.0
|
ribosomal protein S6 kinase A5
|
MSK1/MSK1(RPS6KA5) |
Hs |
Inhibitor |
Inhibition |
59.0
|
80.0
|
31.0
|
spleen associated tyrosine kinase
|
Syk/SYK |
Hs |
Inhibitor |
Inhibition |
59.2
|
92.0
|
33.0
|
fyn related Src family tyrosine kinase
|
PTK5/FRK(PTK5) |
Hs |
Inhibitor |
Inhibition |
59.3
|
31.0
|
1.0
|
TTK protein kinase
|
nd/TTK |
Hs |
Inhibitor |
Inhibition |
59.8
|
|
|
CDC42 binding protein kinase alpha
|
MRCKα/MRCKa(CDC42BPA) |
Hs |
Inhibitor |
Inhibition |
60.0
|
118.0
|
113.0
|
calcium/calmodulin dependent protein kinase ID
|
CaMKIδ/CAMK1d |
Hs |
Inhibitor |
Inhibition |
60.2
|
42.0
|
6.0
|
EPH receptor B1
|
EphB1/EPHB1 |
Hs |
Inhibitor |
Inhibition |
60.8
|
64.0
|
24.0
|
homeodomain interacting protein kinase 4
|
nd/HIPK1 |
Hs |
Inhibitor |
Inhibition |
61.7
|
|
|
G protein-coupled receptor kinase 7
|
GRK7/GRK7 |
Hs |
Inhibitor |
Inhibition |
62.2
|
57.0
|
9.0
|
serum/glucocorticoid regulated kinase 2
|
SGK2/SGK2 |
Hs |
Inhibitor |
Inhibition |
62.8
|
60.0
|
32.0
|
muscle associated receptor tyrosine kinase
|
MuSK/MUSK |
Hs |
Inhibitor |
Inhibition |
63.5
|
3.0
|
0.0
|
Protein kinase G (PKG) 1
|
PKG1α/PKG1a |
Hs |
Inhibitor |
Inhibition |
64.2
|
89.0
|
51.0
|
casein kinase 2, alpha prime polypeptide subunit
|
CK2α2/CK2a2 |
Hs |
Inhibitor |
Inhibition |
64.3
|
113.0
|
47.0
|
Janus kinase 1
|
nd/JAK1 |
Hs |
Inhibitor |
Inhibition |
65.8
|
|
|
TAO kinase 1
|
TAO1/TAOK1 |
Hs |
Inhibitor |
Inhibition |
65.8
|
71.0
|
18.0
|
testis specific serine kinase 2
|
TSSK2/TSSK2 |
Hs |
Inhibitor |
Inhibition |
66.9
|
62.0
|
26.0
|
EPH receptor A7
|
EphA7/EPHA7 |
Hs |
Inhibitor |
Inhibition |
67.1
|
79.0
|
24.0
|
casein kinase 1 gamma 1
|
CK1γ1/CK1g1 |
Hs |
Inhibitor |
Inhibition |
69.2
|
64.0
|
14.0
|
fibroblast growth factor receptor 4
|
FGFR4/FGFR4 |
Hs |
Inhibitor |
Inhibition |
70.5
|
101.0
|
47.0
|
pregnancy up-regulated nonubiquitous CaM kinase
|
nd/CAMK1b |
Hs |
Inhibitor |
Inhibition |
70.5
|
|
|
NUAK family, SNF1-like kinase, 2
|
nd/SNARK(NUAK2) |
Hs |
Inhibitor |
Inhibition |
70.7
|
|
|
TAO kinase 2
|
TAO2/TAOK2(TAO1) |
Hs |
Inhibitor |
Inhibition |
72.6
|
89.0
|
35.0
|
cyclin dependent kinase 7
|
CDK7-cyclin H-MAT1/CDK7-cyclin H |
Hs |
Inhibitor |
Inhibition |
72.8
|
15.0
|
2.0
|
serine/threonine kinase 16
|
nd/STK16 |
Hs |
Inhibitor |
Inhibition |
72.9
|
|
|
serine/threonine-protein kinase MST4
|
nd/MSTR4 |
Hs |
Inhibitor |
Inhibition |
73.2
|
|
|
Rho associated coiled-coil containing protein kinase 2
|
ROCK-II/ROCK2 |
Hs |
Inhibitor |
Inhibition |
73.5
|
86.0
|
32.0
|
Pim-3 proto-oncogene, serine/threonine kinase
|
Pim-3/PIM3 |
Hs |
Inhibitor |
Inhibition |
74.0
|
92.0
|
75.0
|
cyclin dependent kinase 4
|
nd/CDK4/cyclin D1 |
Hs |
Inhibitor |
Inhibition |
74.1
|
|
|
aurora kinase C
|
Aurora-C/Aurora C |
Hs |
Inhibitor |
Inhibition |
74.7
|
38.0
|
5.0
|
MAPK interacting serine/threonine kinase 1
|
nd/MNK1 |
Hs |
Inhibitor |
Inhibition |
75.4
|
|
|
casein kinase 1 alpha 1
|
nd/CK1a1 |
Hs |
Inhibitor |
Inhibition |
75.7
|
|
|
calcium/calmodulin dependent protein kinase I
|
CaMKI/CAMK1a |
Hs |
Inhibitor |
Inhibition |
75.9
|
51.0
|
-2.0
|
Protein kinase G (PKG) 1
|
PKG1β/PKG1b |
Hs |
Inhibitor |
Inhibition |
76.4
|
63.0
|
27.0
|
p21 (RAC1) activated kinase 4
|
PAK4/PAK4 |
Hs |
Inhibitor |
Inhibition |
76.7
|
52.0
|
11.0
|
EPH receptor B4
|
EphB4/EPHB4 |
Hs |
Inhibitor |
Inhibition |
76.9
|
100.0
|
35.0
|
MET proto-oncogene, receptor tyrosine kinase
|
Met/c-MET |
Hs |
Inhibitor |
Inhibition |
77.0
|
45.0
|
7.0
|
NIMA related kinase 2
|
NEK2/NEK2 |
Hs |
Inhibitor |
Inhibition |
77.2
|
67.0
|
18.0
|
TXK tyrosine kinase
|
Txk/TXK |
Hs |
Inhibitor |
Inhibition |
79.5
|
70.0
|
21.0
|
tousled like kinase 2
|
TLK2/TLK2 |
Hs |
Inhibitor |
Inhibition |
79.6
|
69.0
|
14.0
|
oxidative stress responsive kinase 1
|
nd/OSR1(OXSR1) |
Hs |
Inhibitor |
Inhibition |
80.1
|
|
|
aurora kinase A
|
Aurora-A/Aurora A |
Hs |
Inhibitor |
Inhibition |
80.3
|
47.0
|
30.0
|
serine/threonine kinase 11
|
LKB1/LKB1 |
Hs |
Inhibitor |
Inhibition |
80.7
|
98.0
|
86.0
|
G protein-coupled receptor kinase 4
|
nd/GRK4 |
Hs |
Inhibitor |
Inhibition |
80.8
|
|
|
dual specificity tyrosine phosphorylation regulated kinase 3
|
nd/DYRK3 |
Hs |
Inhibitor |
Inhibition |
81.8
|
|
|
serine/threonine kinase 39
|
nd/STK39(STLK3) |
Hs |
Inhibitor |
Inhibition |
81.9
|
|
|
Protein kinase G (PKG) 2
|
nd/PKG2(PRKG2) |
Hs |
Inhibitor |
Inhibition |
82.6
|
|
|
dual specificity tyrosine phosphorylation regulated kinase 2
|
DYRK2/DYRK2 |
Hs |
Inhibitor |
Inhibition |
82.7
|
78.0
|
37.0
|
G protein-coupled receptor kinase 5
|
GRK5/GRK5 |
Hs |
Inhibitor |
Inhibition |
82.7
|
68.0
|
33.0
|
mitogen-activated protein kinase kinase kinase 10
|
nd/MLK2(MAP3K10) |
Hs |
Inhibitor |
Inhibition |
82.8
|
|
|
doublecortin like kinase 2
|
DCAMKL2/DCAMKL2 |
Hs |
Inhibitor |
Inhibition |
82.8
|
68.0
|
24.0
|
histone H3 associated protein kinase
|
Haspin/Haspin |
Hs |
Inhibitor |
Inhibition |
82.9
|
43.0
|
12.0
|
NIMA related kinase 11
|
NEK11/NEK11 |
Hs |
Inhibitor |
Inhibition |
83.4
|
80.0
|
31.0
|
protein kinase X-linked
|
PrKX/PRKX |
Hs |
Inhibitor |
Inhibition |
83.9
|
63.0
|
37.0
|
receptor interacting serine/threonine kinase 2
|
RIPK2/RIPK2 |
Hs |
Inhibitor |
Inhibition |
84.1
|
62.0
|
27.0
|
AKT serine/threonine kinase 3
|
PKBγ/AKT3 |
Hs |
Inhibitor |
Inhibition |
84.2
|
79.0
|
33.0
|
protein kinase N2
|
PRK2/PKN2(PRK2) |
Hs |
Inhibitor |
Inhibition |
84.4
|
52.0
|
18.0
|
erb-b2 receptor tyrosine kinase 4
|
ErbB4/ERBB4(HER4) |
Hs |
Inhibitor |
Inhibition |
86.1
|
86.0
|
104.0
|
protein kinase C eta
|
PKCη/PKCeta |
Hs |
Inhibitor |
Inhibition |
86.1
|
110.0
|
81.0
|
cyclin dependent kinase 5
|
CDK5-p35/CDK5-p35 |
Hs |
Inhibitor |
Inhibition |
86.2
|
72.0
|
28.0
|
mitogen-activated protein kinase kinase 6
|
MKK6/MKK6 |
Hs |
Inhibitor |
Inhibition |
86.2
|
66.0
|
46.0
|
C-terminal Src kinase
|
CSK/CSK |
Hs |
Inhibitor |
Inhibition |
86.3
|
99.0
|
84.0
|
cyclin dependent kinase 4
|
nd/CDK4/cyclin D3 |
Hs |
Inhibitor |
Inhibition |
86.3
|
|
|
WNK lysine deficient protein kinase 3
|
WNK3/WNK3 |
Hs |
Inhibitor |
Inhibition |
86.3
|
94.0
|
63.0
|
death associated protein kinase 2
|
DAPK2/DAPK2 |
Hs |
Inhibitor |
Inhibition |
86.7
|
63.0
|
16.0
|
AKT serine/threonine kinase 2
|
PKBβ/AKT2 |
Hs |
Inhibitor |
Inhibition |
86.9
|
91.0
|
33.0
|
EPH receptor B2
|
EphB2/EPHB2 |
Hs |
Inhibitor |
Inhibition |
87.5
|
89.0
|
36.0
|
cyclin dependent kinase 1
|
nd/CDK1-cyclin A |
Hs |
Inhibitor |
Inhibition |
87.5
|
|
|
EPH receptor A4
|
EphA4/EPHA4 |
Hs |
Inhibitor |
Inhibition |
88.0
|
101.0
|
62.0
|
glycogen synthase kinase 3 alpha
|
GSK3α/GSK3a |
Hs |
Inhibitor |
Inhibition |
88.3
|
104.0
|
84.0
|
cyclin dependent kinase 3
|
CDK3-cyclin E/CDK3-cyclin E |
Hs |
Inhibitor |
Inhibition |
88.3
|
87.0
|
44.0
|
MAPK interacting serine/threonine kinase 2
|
Mnk2/MNK2 |
Hs |
Inhibitor |
Inhibition |
88.8
|
99.0
|
45.0
|
activin A receptor type IL
|
nd/ALK1(ACVRL1) |
Hs |
Inhibitor |
Inhibition |
89.0
|
|
|
EPH receptor A1
|
EphA1/EPHA1 |
Hs |
Inhibitor |
Inhibition |
89.4
|
82.0
|
37.0
|
PAS domain containing serine/threonine kinase
|
PASK/PASK |
Hs |
Inhibitor |
Inhibition |
89.6
|
70.0
|
49.0
|
Rho associated coiled-coil containing protein kinase 1
|
ROCK-I/ROCK1 |
Hs |
Inhibitor |
Inhibition |
89.7
|
101.0
|
90.0
|
polo like kinase 3
|
Plk3/PLK3 |
Hs |
Inhibitor |
Inhibition |
89.8
|
94.0
|
95.0
|
cyclin dependent kinase 2
|
CDK2/cyclin E |
Hs |
Inhibitor |
Inhibition |
90.0
|
|
|
protein kinase, cAMP-dependent, catalytic, alpha subunit
|
PKA/PKA |
Hs |
Inhibitor |
Inhibition |
90.0
|
81.0
|
93.0
|
protein kinase C delta
|
PKCδ/PKCd |
Hs |
Inhibitor |
Inhibition |
90.4
|
95.0
|
68.0
|
EPH receptor A5
|
EphA5/EPHA5 |
Hs |
Inhibitor |
Inhibition |
90.4
|
109.0
|
55.0
|
VRK serine/threonine kinase 1
|
nd/VRK1 |
Hs |
Inhibitor |
Inhibition |
90.7
|
|
|
polo like kinase 2
|
Snk/PLK2 |
Hs |
Inhibitor |
Inhibition |
91.2
|
98.0
|
58.0
|
zeta chain of T cell receptor associated protein kinase 70
|
ZAP-70/ZAP70 |
Hs |
Inhibitor |
Inhibition |
91.2
|
116.0
|
77.0
|
casein kinase 2, alpha 1 polypeptide subunit
|
CK2/CK2a |
Hs |
Inhibitor |
Inhibition |
91.4
|
86.0
|
70.0
|
ribosomal protein S6 kinase B2
|
nd/p70S6Kb(RPS6KB2) |
Hs |
Inhibitor |
Inhibition |
91.6
|
|
|
MAPK activated protein kinase 5
|
PRAK/MAPKAPK5(PRAK) |
Hs |
Inhibitor |
Inhibition |
91.6
|
97.0
|
49.0
|
Pim-1 proto-oncogene, serine/threonine kinase
|
Pim-1/PIM1 |
Hs |
Inhibitor |
Inhibition |
91.7
|
85.0
|
67.0
|
protein kinase C iota
|
PKCι/PKCiota |
Hs |
Inhibitor |
Inhibition |
91.9
|
84.0
|
79.0
|
EPH receptor A3
|
EphA3/EPHA3 |
Hs |
Inhibitor |
Inhibition |
92.5
|
94.0
|
47.0
|
p21 (RAC1) activated kinase 2
|
PAK2/PAK2 |
Hs |
Inhibitor |
Inhibition |
92.7
|
110.0
|
81.0
|
cyclin dependent kinase 2
|
CDK2-cyclin A/CDK2-cyclin A |
Hs |
Inhibitor |
Inhibition |
92.8
|
134.0
|
69.0
|
SRSF protein kinase 3
|
MSSK1/MSSK1(STK23) |
Hs |
Inhibitor |
Inhibition |
92.8
|
98.0
|
61.0
|
glycogen synthase kinase 3 beta
|
GSK3β/GSK3b |
Hs |
Inhibitor |
Inhibition |
93.1
|
87.0
|
62.0
|
protein kinase C alpha
|
PKCα/PKCa |
Hs |
Inhibitor |
Inhibition |
93.1
|
100.0
|
83.0
|
p21 (RAC1) activated kinase 1
|
nd/PAK1 |
Hs |
Inhibitor |
Inhibition |
93.4
|
|
|
EPH receptor A2
|
EphA2/EPHA2 |
Hs |
Inhibitor |
Inhibition |
93.5
|
94.0
|
73.0
|
SRSF protein kinase 2
|
SRPK2/SRPK2 |
Hs |
Inhibitor |
Inhibition |
93.7
|
98.0
|
78.0
|
p21 (RAC1) activated kinase 3
|
PAK3/PAK3 |
Hs |
Inhibitor |
Inhibition |
93.8
|
64.0
|
4.0
|
NIMA related kinase 3
|
NEK3/NEK3 |
Hs |
Inhibitor |
Inhibition |
94.0
|
111.0
|
73.0
|
NIMA related kinase 1
|
nd/NEK1 |
Hs |
Inhibitor |
Inhibition |
94.7
|
|
|
WEE1 G2 checkpoint kinase
|
nd/WEE1 |
Hs |
Inhibitor |
Inhibition |
94.8
|
|
|
calcium/calmodulin dependent protein kinase IV
|
CaMKIV/CAMK4 |
Hs |
Inhibitor |
Inhibition |
95.0
|
88.0
|
15.0
|
cyclin dependent kinase 5
|
CDK5-p25/CDK5-p25 |
Hs |
Inhibitor |
Inhibition |
95.1
|
77.0
|
22.0
|
transforming growth factor beta receptor 1
|
TGFBR1/ALK5(TGFBR1) |
Hs |
Inhibitor |
Inhibition |
95.5
|
101.0
|
83.0
|
Serine/threonine kinase 38
|
nd/STK38(NDR1) |
Hs |
Inhibitor |
Inhibition |
95.8
|
|
|
ZAK sterile alpha motif and leucine zipper containing kinase AZK
|
nd/ZAK(MLTK) |
Hs |
Inhibitor |
Inhibition |
95.8
|
|
|
NIMA related kinase 9
|
nd/NEK9 |
Hs |
Inhibitor |
Inhibition |
95.9
|
|
|
SRSF protein kinase 1
|
SRPK1/SRPK1 |
Hs |
Inhibitor |
Inhibition |
95.9
|
112.0
|
94.0
|
CDC42 binding protein kinase beta
|
MRCKβ/MRCKb(CDC42BPB) |
Hs |
Inhibitor |
Inhibition |
96.1
|
103.0
|
91.0
|
mitogen-activated protein kinase 12
|
SAPK3/P38g |
Hs |
Inhibitor |
Inhibition |
96.6
|
108.0
|
92.0
|
macrophage stimulating 1 receptor
|
Ron/RON(MSTR1) |
Hs |
Inhibitor |
Inhibition |
96.7
|
91.0
|
40.0
|
megakaryocyte-associated tyrosine kinase
|
nd/CTK(MATK) |
Hs |
Inhibitor |
Inhibition |
96.8
|
|
|
homeodomain interacting protein kinase 1
|
HIPK1/HIPK1 |
Hs |
Inhibitor |
Inhibition |
96.9
|
32.0
|
4.0
|
NIMA related kinase 4
|
nd/NEK4 |
Hs |
Inhibitor |
Inhibition |
97.0
|
|
|
epidermal growth factor receptor
|
EGFR/EGFR |
Hs |
Inhibitor |
Inhibition |
97.0
|
107.0
|
110.0
|
mitogen-activated protein kinase 1
|
MAPK2/ERK2(MAPK1) |
Hs |
Inhibitor |
Inhibition |
97.1
|
97.0
|
91.0
|
mitogen-activated protein kinase 8
|
JNK1α1/JNK1 |
Hs |
Inhibitor |
Inhibition |
97.2
|
97.0
|
82.0
|
beta adrenergic receptor kinase 2
|
nd/GRK3 |
Hs |
Inhibitor |
Inhibition |
97.8
|
|
|
NIMA related kinase 6
|
NEK6/NEK6 |
Hs |
Inhibitor |
Inhibition |
97.8
|
91.0
|
96.0
|
dual specificity tyrosine phosphorylation regulated kinase 4
|
nd/DYRK4 |
Hs |
Inhibitor |
Inhibition |
97.9
|
|
|
mitogen-activated protein kinase kinase kinase 5
|
ASK1/ASK1(MAP3K5) |
Hs |
Inhibitor |
Inhibition |
98.1
|
60.0
|
43.0
|
protein kinase C beta
|
PKCβI/PKCb1 |
Hs |
Inhibitor |
Inhibition |
98.1
|
125.0
|
117.0
|
TEK receptor tyrosine kinase
|
Tie2/TIE2(TEK) |
Hs |
Inhibitor |
Inhibition |
98.2
|
56.0
|
19.0
|
LIM domain kinase 1
|
LIMK1/LIMK1 |
Hs |
Inhibitor |
Inhibition |
98.4
|
99.0
|
44.0
|
mitogen-activated protein kinase 3
|
MAPK1/ERK1 |
Hs |
Inhibitor |
Inhibition |
98.8
|
91.0
|
115.0
|
NIMA related kinase 7
|
NEK7/NEK7 |
Hs |
Inhibitor |
Inhibition |
99.3
|
102.0
|
109.0
|
BMX non-receptor tyrosine kinase
|
Bmx/BMX(ETK) |
Hs |
Inhibitor |
Inhibition |
99.3
|
73.0
|
36.0
|
EPH receptor A8
|
EphA8/EPHA8 |
Hs |
Inhibitor |
Inhibition |
99.5
|
100.0
|
55.0
|
mitogen-activated protein kinase 11
|
SAPK2b/P38b(MAPK11) |
Hs |
Inhibitor |
Inhibition |
100.0
|
95.0
|
92.0
|
EPH receptor B3
|
EphB3/EPHB3 |
Hs |
Inhibitor |
Inhibition |
100.1
|
129.0
|
130.0
|
p21 (RAC1) activated kinase 6
|
PAK6/PAK6 |
Hs |
Inhibitor |
Inhibition |
100.5
|
73.0
|
28.0
|
WNK lysine deficient protein kinase 2
|
WNK2/WNK2 |
Hs |
Inhibitor |
Inhibition |
100.8
|
105.0
|
54.0
|
nemo like kinase
|
NLK/NLK |
Hs |
Inhibitor |
Inhibition |
100.9
|
102.0
|
86.0
|
inhibitor of nuclear factor kappa B kinase subunit beta
|
IKKβ/IKKb(IKBKB) |
Hs |
Inhibitor |
Inhibition |
100.9
|
98.0
|
79.0
|
MAPK activated protein kinase 3
|
MAPKAP-K3/MAPKAPK3 |
Hs |
Inhibitor |
Inhibition |
100.9
|
108.0
|
106.0
|
CDC like kinase 3
|
CLK3/CLK3 |
Hs |
Inhibitor |
Inhibition |
101.1
|
77.0
|
4.0
|
Pim-2 proto-oncogene, serine/threonine kinase
|
Pim-2/PIM2 |
Hs |
Inhibitor |
Inhibition |
101.3
|
99.0
|
92.0
|
protein kinase C gamma
|
PKCγ/PKCg |
Hs |
Inhibitor |
Inhibition |
101.4
|
94.0
|
51.0
|
protein kinase, cAMP-dependent, catalytic, gamma subunit
|
nd/PKAcg |
Hs |
Inhibitor |
Inhibition |
101.5
|
|
|
3-phosphoinositide dependent protein kinase 1
|
PDK1/PDK1(PDPK1) |
Hs |
Inhibitor |
Inhibition |
101.5
|
78.0
|
39.0
|
component of inhibitor of nuclear factor kappa B kinase complex
|
IKKα/IKKA(CHUK) |
Hs |
Inhibitor |
Inhibition |
101.6
|
93.0
|
65.0
|
DM1 protein kinase
|
DMPK/DMPK |
Hs |
Inhibitor |
Inhibition |
101.6
|
52.0
|
68.0
|
src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites
|
nd/SRMS |
Hs |
Inhibitor |
Inhibition |
101.7
|
|
|
AKT serine/threonine kinase 1
|
PKBα/AKT1 |
Hs |
Inhibitor |
Inhibition |
101.9
|
99.0
|
103.0
|
protein kinase C epsilon
|
PKCε/PKCepsilon |
Hs |
Inhibitor |
Inhibition |
102.0
|
99.0
|
108.0
|
tec protein tyrosine kinase
|
nd/TEC |
Hs |
Inhibitor |
Inhibition |
102.2
|
|
|
erb-b2 receptor tyrosine kinase 2
|
nd/ERBB2(HER2) |
Hs |
Inhibitor |
Inhibition |
102.3
|
|
|
mitogen-activated protein kinase 14
|
SAPK2a/P38a(MAPK14) |
Hs |
Inhibitor |
Inhibition |
102.6
|
82.0
|
52.0
|
serum/glucocorticoid regulated kinase family member 3
|
SGK3/SGK3 |
Hs |
Inhibitor |
Inhibition |
102.6
|
115.0
|
73.0
|
MAPK activated protein kinase 2
|
MAPKAP-K2/MAPKAPK2 |
Hs |
Inhibitor |
Inhibition |
102.9
|
98.0
|
86.0
|
activin A receptor type 1B
|
nd/ALK4(ACVR1B) |
Hs |
Inhibitor |
Inhibition |
103.2
|
126.0
|
99.0
|
protein kinase C zeta
|
PKCζ/PKCzeta |
Hs |
Inhibitor |
Inhibition |
103.5
|
103.0
|
107.0
|
mitogen-activated protein kinase 13
|
SAPK4/P38d(MAPK13) |
Hs |
Inhibitor |
Inhibition |
103.6
|
100.0
|
88.0
|
PDZ binding kinase
|
nd/PBK(TOPK) |
Hs |
Inhibitor |
Inhibition |
103.9
|
|
|
beta adrenergic receptor kinase 1
|
nd/GRK2 |
Hs |
Inhibitor |
Inhibition |
103.9
|
|
|
discoidin domain receptor tyrosine kinase 2
|
DDR2/DDR2 |
Hs |
Inhibitor |
Inhibition |
104.2
|
94.0
|
44.0
|
mitogen-activated protein kinase 10
|
JNK3/JNK3 |
Hs |
Inhibitor |
Inhibition |
104.5
|
80.0
|
75.0
|
protein kinase C theta
|
PKCθ/PKCtheta |
Hs |
Inhibitor |
Inhibition |
104.7
|
102.0
|
65.0
|
dual serine/threonine and tyrosine protein kinase
|
nd/RIPK5 |
Hs |
Inhibitor |
Inhibition |
104.9
|
|
|
polo like kinase 1
|
Plk1/PLK1 |
Hs |
Inhibitor |
Inhibition |
105.1
|
92.0
|
55.0
|
activin A receptor type 1
|
nd/ALK2(ACVR1) |
Hs |
Inhibitor |
Inhibition |
107.8
|
|
|
mitogen-activated protein kinase 9
|
JNK2α2/JNK2 |
Hs |
Inhibitor |
Inhibition |
108.5
|
111.0
|
95.0
|
cyclin dependent kinase 1
|
CDK1-cyclin B/CDK1-cyclin B |
Hs |
Inhibitor |
Inhibition |
108.9
|
93.0
|
57.0
|
B-Raf proto-oncogene, serine/threonine kinase
|
nd/BRAF |
Hs |
Inhibitor |
Inhibition |
109.0
|
|
|
protein kinase C beta
|
PKCβII/PKCb2 |
Hs |
Inhibitor |
Inhibition |
109.6
|
105.0
|
94.0
|
transforming growth factor beta receptor 2
|
nd/TGFBR2 |
Hs |
Inhibitor |
Inhibition |
112.8
|
|
|
mitogen-activated protein kinase kinase kinase 8
|
nd/COT1(MAP3K8) |
Hs |
Inhibitor |
Inhibition |
113.1
|
|
|
Raf-1 proto-oncogene, serine/threonine kinase
|
c-RAF/RAF1 |
Hs |
Inhibitor |
Inhibition |
116.8
|
97.0
|
102.0
|
mitogen-activated protein kinase kinase kinase 14
|
nd/NIK(MAP3K14) |
Hs |
Inhibitor |
Inhibition |
118.4
|
|
|
A-Raf proto-oncogene, serine/threonine kinase
|
nd/ARAF |
Hs |
Inhibitor |
Inhibition |
132.1
|
|
|
protein kinase AMP-activated catalytic subunit alpha 2
|
AMPKα2/nd |
Hs |
Inhibitor |
Inhibition |
|
4.0
|
4.0
|
LCK proto-oncogene, Src family tyrosine kinase
|
Lck activated |
Hs |
Inhibitor |
Inhibition |
|
6.0
|
-1.0
|
protein kinase AMP-activated catalytic subunit alpha 1
|
AMPKα1/nd |
Hs |
Inhibitor |
Inhibition |
|
7.0
|
3.0
|
Insulin receptor
|
IR (activated)/nd |
Hs |
Inhibitor |
Inhibition |
|
8.0
|
0.0
|
HCK proto-oncogene, Src family tyrosine kinase
|
Hck (activated)/nd |
Hs |
Inhibitor |
Inhibition |
|
9.0
|
0.0
|
Insulin-like growth factor I receptor
|
IGF-1R (activated)/nd |
Hs |
Inhibitor |
Inhibition |
|
30.0
|
3.0
|
salt inducible kinase 1
|
SIK/nd |
Hs |
Inhibitor |
Inhibition |
|
31.0
|
5.0
|
tec protein tyrosine kinase
|
Tec (activated)/nd |
Hs |
Inhibitor |
Inhibition |
|
78.0
|
29.0
|
mitogen-activated protein kinase kinase 7
|
MKK7β/nd |
Hs |
Inhibitor |
Inhibition |
|
92.0
|
81.0
|
cyclin dependent kinase 2
|
CDK2/cyclinE |
Hs |
Inhibitor |
Inhibition |
|
98.0
|
65.0
|
mechanistic target of rapamycin kinase
|
mTOR/nd |
Hs |
Inhibitor |
Inhibition |
|
102.0
|
118.0
|
eukaryotic elongation factor 2 kinase
|
eEF-2K/nd |
Hs |
Inhibitor |
Inhibition |
|
105.0
|
85.0
|
VRK serine/threonine kinase 2
|
VRK2/nd |
Hs |
Inhibitor |
Inhibition |
|
108.0
|
86.0
|
mechanistic target of rapamycin kinase
|
mTOR-FKBP12/nd |
Hs |
Inhibitor |
Inhibition |
|
115.0
|
102.0
|